The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 



